THE TREATMENT OF BRCA1/2 HEREDITARY BREAST CANCER AND SPORADIC BREAST CANCER WITH POLY (ADP-RIBOSE) POLYMERASE (PARP-1) INHIBITORS AND CHEMOTHERAPY
$270,903FY2008Department of DefenseDOD
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc.